Collaborative, mission-driven, results-oriented, and strategic in their use of capital, the participating organizations of TRAIN are motivated solely by moving promising therapies from the laboratory bench to the patient's bedside as rapidly as possible - even those that do not directly fund therapy development. Supporting translational research is a critical part of their mission.